SHUKRAPHAR · Shukra Pharmaceuticals Ltd · Biotechnology & Drugs
SHUKRAPHAR · Shukra Pharmaceuticals Ltd · Biotechnology & Drugs
₹79.88-0.0%
As of 06 Nov close
52-week range. Price history incomplete · as of 06 Nov 2026
Price chartDaily closes on the stock page.
Stock Condition:Pro
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 16 Oct 2026
Operating margin above its own averagePromoter holding rose this quarter
Revenue (latest Q)
₹24 Cr
Revenue YoY
PAT YoY
+1158.3%
Operating margin
Revenue, last 5 quarters
P/E (TTM)
P/B
33.6
P/S (TTM)
39.5
Sector P/E
33.6
Dividend yield
+0.0%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| SHUKRAPHAR (this stock) | Not available from data source | 33.6 | +45.4% | +37.8% | 0.06 | +0.0% |
| Sun Pharmaceutical Industries | 38.4 | 5.6 | +19.1% | +14.2% | 0.47 | +0.8% |
| Divi's Laboratories | 59.7 | 14.5 | +26.1% | +17.4% | 0 | +0.3% |
| Torrent Pharmaceuticals | 72.7 | 19.2 | +15.3% | +27.1% | 141.16 | +0.8% |
Promoter
rising 1q
FII
Not available from data source
MF
Not available from data source
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
| canonicalSymbol | date | buy quantity | buyer count | deal strength | deal types present |
|---|---|---|---|---|---|
| SHUKRAPHAR | 2026-10-29 | 2699471 | 1 | WEAK | BULK |
| SHUKRAPHAR | 2026-10-23 | 3369454 | 1 | WEAK | BULK |
| SHUKRAPHAR | 2026-10-05 | 9768877 | 3 | MEDIUM | BULK |
News timeline
No related news.
Concalls & investor presentations
AI-generatedNo concall transcripts or investor presentations recorded yet.
Governance disclosures
AI-generatedNo governance disclosures identified in SHUKRAPHAR's filed documents yet.